Towards Healthcare
Multiple Sclerosis Diagnosis and Treatment Market Top Companies

Multiple Sclerosis Diagnosis and Treatment Market Size Envisioned at USD 30.28 Billion by 2032

The report covers Multiple Sclerosis (MS) Diagnosis and Treatment Market Analysis and Companies such as Siemens Healthineers AG and General Electric Company, F. Hoffmann-La Roche Ltd., Biogen Inc., Merck & Co., Inc., Novartis AG, and Sanofi S.A., Bristol Myers Squibb Company, Teva Pharmaceutical Industries Ltd. and Abbott Laboratories. The report offers the value (in USD Billion) for the above segments.

Content

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

Global Multiple Sclerosis Diagnosis and Treatment Market Assessment

  • Overview
  • Global Multiple Sclerosis Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Clinically Isolated Syndrome (CIS)
    • Relapse-Remitting MS (RRMS)
    • Primary Progressive MS (PPMS)
    • Secondary Progressive MS (SPMS)
  • Global Multiple Sclerosis Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Diagnosis (2021 – 2033)
    • Imaging Tests
    • Spinal Fluid Analysis
    • Other Tests
  • Global Multiple Sclerosis Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Treatment (2021 – 2033)
    • Medications
      • Injectables
        • Beta Interferons
        • Glatiramer Acetate
      • Oral Medications
        • Fingolimod
        • Dimethyl Fumarate
        • Teriflunomide
        • Cladribine
        • Diroximel Fumarate
        • Siponimod Tablets
      • Infusion Treatments
        • Natalizumab
        • Ocrelizumab
        • Alemtuzumab
        • Mitoxantrone
    • Physical, Occupational or Speech Therapy
    • Mental Health Counselling
  • Global Multiple Sclerosis Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Geography (2021 – 2033)
    • North America
    • Europe
    • Asia Pacific
    • Middle East and Africa
    • South America

North America Multiple Sclerosis Diagnosis and Treatment Market Assessment

  • Overview
  • North America Multiple Sclerosis Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Clinically Isolated Syndrome (CIS)
    • Relapse-Remitting MS (RRMS)
    • Primary Progressive MS (PPMS)
    • Secondary Progressive MS (SPMS)
  • North America Multiple Sclerosis Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Diagnosis (2021 – 2033)
    • Imaging Tests
    • Spinal Fluid Analysis
    • Other Tests
  • North America Multiple Sclerosis Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Treatment (2021 – 2033)
    • Medications
      • Injectables
        • Beta Interferons
        • Glatiramer Acetate
      • Oral Medications
        • Fingolimod
        • Dimethyl Fumarate
        • Teriflunomide
        • Cladribine
        • Diroximel Fumarate
        • Siponimod Tablets
      • Infusion Treatments
        • Natalizumab
        • Ocrelizumab
        • Alemtuzumab
        • Mitoxantrone
    • Physical, Occupational or Speech Therapy
    • Mental Health Counselling

Europe Multiple Sclerosis Diagnosis and Treatment Market Assessment

  • Overview
  • Europe Multiple Sclerosis Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Clinically Isolated Syndrome (CIS)
    • Relapse-Remitting MS (RRMS)
    • Primary Progressive MS (PPMS)
    • Secondary Progressive MS (SPMS)
  • Europe Multiple Sclerosis Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Diagnosis (2021 – 2033)
    • Imaging Tests
    • Spinal Fluid Analysis
    • Other Tests
  • Europe Multiple Sclerosis Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Treatment (2021 – 2033)
    • Medications
      • Injectables
        • Beta Interferons
        • Glatiramer Acetate
      • Oral Medications
        • Fingolimod
        • Dimethyl Fumarate
        • Teriflunomide
        • Cladribine
        • Diroximel Fumarate
        • Siponimod Tablets
      • Infusion Treatments
        • Natalizumab
        • Ocrelizumab
        • Alemtuzumab
        • Mitoxantrone
    • Physical, Occupational or Speech Therapy
    • Mental Health Counselling

Asia Pacific Multiple Sclerosis Diagnosis and Treatment Market Assessment

  • Overview
  • Asia Pacific Multiple Sclerosis Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Clinically Isolated Syndrome (CIS)
    • Relapse-Remitting MS (RRMS)
    • Primary Progressive MS (PPMS)
    • Secondary Progressive MS (SPMS)
  • Asia Pacific Multiple Sclerosis Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Diagnosis (2021 – 2033)
    • Imaging Tests
    • Spinal Fluid Analysis
    • Other Tests
  • Asia Pacific Multiple Sclerosis Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Treatment (2021 – 2033)
    • Medications
      • Injectables
        • Beta Interferons
        • Glatiramer Acetate
      • Oral Medications
        • Fingolimod
        • Dimethyl Fumarate
        • Teriflunomide
        • Cladribine
        • Diroximel Fumarate
        • Siponimod Tablets
      • Infusion Treatments
        • Natalizumab
        • Ocrelizumab
        • Alemtuzumab
        • Mitoxantrone
    • Physical, Occupational or Speech Therapy
    • Mental Health Counselling

Middle East and Africa Multiple Sclerosis Diagnosis and Treatment Market Assessment

  • Overview
  • Middle East and Africa Multiple Sclerosis Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Clinically Isolated Syndrome (CIS)
    • Relapse-Remitting MS (RRMS)
    • Primary Progressive MS (PPMS)
    • Secondary Progressive MS (SPMS)
  • Middle East and Africa Multiple Sclerosis Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Diagnosis (2021 – 2033)
    • Imaging Tests
    • Spinal Fluid Analysis
    • Other Tests
  • Middle East and Africa Multiple Sclerosis Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Treatment (2021 – 2033)
    • Medications
      • Injectables
        • Beta Interferons
        • Glatiramer Acetate
      • Oral Medications
        • Fingolimod
        • Dimethyl Fumarate
        • Teriflunomide
        • Cladribine
        • Diroximel Fumarate
        • Siponimod Tablets
      • Infusion Treatments
        • Natalizumab
        • Ocrelizumab
        • Alemtuzumab
        • Mitoxantrone
    • Physical, Occupational or Speech Therapy
    • Mental Health Counselling

South America Multiple Sclerosis Diagnosis and Treatment Market Assessment

  • Overview
  • South America Multiple Sclerosis Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Clinically Isolated Syndrome (CIS)
    • Relapse-Remitting MS (RRMS)
    • Primary Progressive MS (PPMS)
    • Secondary Progressive MS (SPMS)
  • South America Multiple Sclerosis Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Diagnosis (2021 – 2033)
    • Imaging Tests
    • Spinal Fluid Analysis
    • Other Tests
  • South America Multiple Sclerosis Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Treatment (2021 – 2033)
    • Medications
      • Injectables
        • Beta Interferons
        • Glatiramer Acetate
      • Oral Medications
        • Fingolimod
        • Dimethyl Fumarate
        • Teriflunomide
        • Cladribine
        • Diroximel Fumarate
        • Siponimod Tablets
      • Infusion Treatments
        • Natalizumab
        • Ocrelizumab
        • Alemtuzumab
        • Mitoxantrone
    • Physical, Occupational or Speech Therapy
    • Mental Health Counselling

Company Profiles

  • Siemens Healthineers AG
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • General Electric Company
  • F. Hoffmann-La Roche Ltd.
  • Biogen Inc.
  • Merck & Co., Inc.
  • Novartis AG
  • Sanofi S.A.
  • Bristol Myers Squibb Company
  • Teva Pharmaceutical Industries Ltd.
  • Abbott Laboratories

Conclusion & Recommendations

  • Insight Code: 5140
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: May 2024
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

Proceed To Buy

USD 5400
USD 3800
USD 2100
USD 2100
USD 7500

About The Author

Deepa has certified the degree of Master’s in Pharmacy in the Pharmaceutical Quality Assurance department from Dr D.Y. Patil College of Pharmacy. Her research is focused on the healthcare industry. She is the author or co-author of four Review Articles, which include Solid dispersion a strategic method for poorly soluble drugs and solubility improvement techniques for poorly soluble drugs, Herbal Drugs Used In Treatment Of Cataracts, Nano sponges And Their Application in Cancer Prevention and Ayurvedic Remedies of Peptic ulcer. She has also published a Research Article on the Formulation and Evaluation of Mucoadhesive Tablets of Miconazole cocrystal which was published in GIS Science Journal Volume 9 Issue 8. Her passion for secondary research and desire to take on the challenge of solving unresolved issues is making her flourish is the in the research sector.

Talk to us
FAQ's

Multiple sclerosis is a chronic autoimmune disease that affects the central nervous system, causing communication problems between the brain and the rest of the body.

Diagnostic tools for multiple sclerosis include magnetic resonance imaging (MRI) to detect lesions in the central nervous system, cerebrospinal fluid analysis to check for abnormalities, and neurological examinations to assess symptoms and signs of the disease.

North America leads the market for multiple sclerosis diagnosis and treatment.

National Institute of Health, Food and Drug Administration, World Health organization, ScienceDirect, HHS.gov., National Multiple Sclerosis Society.
Any Questions